Diagnostics and Tools April 2023

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Epic Sciences, In. closed a $24mm Series A Financing, led by Domain Associates, L.L.C., Arsenal Capital Partners, Deerfield Management Company, L.P. Series C, Blue Ox Healthcare Partners, LLC, Labcorp Venture Fund
• Mission Bio, Inc. closed a Series A Financing, led by Fulgent Genetics, Inc. (NasdaqGM:FLGT)
• Sangon Biotech Engineering (Shanghai) Company Limited closed a $290.4mm Series A Financing, led by GL Capital Group, Greenwoods Investment, Huagai Capital Co., Ltd., CDB Technology Venture Capital Co., Ltd., CPE Yuanfeng, Beiguang Huagai Private Equity Fund Management (Beijing) Co., Ltd.